Join the Zofran ODT group to help and get support from people like you.
Zofran ODT News
FDA Medwatch Alert: Metoclopramide Injection And Ondansetron Injection by Hospira: Recall - Glass Strand Particulates Caused By Glass Supplier
ISSUE: Hospira, Inc. announced it initiated a voluntary nationwide recall of one lot of Metoclopramide Injection, USP, 10 mg/2 mL (5 mg/mL)and two lots of Ondansetron Injection, USP, 4 mg/2 mL, (2 ...
FDA Medwatch Alert: Ondansetron (Zofran) 32 mg, Single Intravenous (IV) Dose: Updated Safety Communication – Product Removal due to Potential For Serious Cardiac Risks
ISSUE: FDA is notifying health care professionals that the 32 mg, single intravenous (IV) dose of the anti-nausea drug Zofran (ondansetron hydrochloride) will no longer be marketed because of the...
FDA Medwatch Alert: Ondansetron (Zofran) IV: Drug Safety Communication - QT prolongation
ISSUE: The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and the public that preliminary results from a recently completed clinical study suggest that a 32 mg single...
FDA Medwatch Alert: Zofran (ondansetron): Drug Safety Communication - Risk of Abnormal Heart Rhythms
ISSUE: FDA notified healthcare professionals and patients of an ongoing safety review and labeling changes for the anti-nausea drug Zofran (ondansetron, ondansetron hydrochloride and generics)....
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Nausea / Vomiting, Nausea / Vomiting - Chemotherapy Induced